# Supplementation With a Highly-Concentrated Docosahexaenoic Acid (DHA) Triglyceride in Patients With Keratoconus

> **NCT05756062** · NA · COMPLETED · sponsor: **Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana** · enrollment: 34 (actual)

## Conditions studied

- Keratoconus

## Interventions

- **DIETARY_SUPPLEMENT:** Highly-concentrated DHA triglyceride (Tridocosahexanoin-AOX 70%)

## Key facts

- **NCT ID:** NCT05756062
- **Lead sponsor:** Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-01
- **Primary completion:** 2022-01-10
- **Final completion:** 2022-01-10
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2023-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05756062

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05756062, "Supplementation With a Highly-Concentrated Docosahexaenoic Acid (DHA) Triglyceride in Patients With Keratoconus". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05756062. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*